VRCA Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.

$2.18  +0.07 (3.32%)
As of 06/27/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/15/2018
Outstanding shares:  27,519,053
Average volume:  381,240
Market cap:   $58,065,202
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BZ1NTH2
Valuation   (See tab for details)
PE ratio:   -7.08
PB ratio:   2.36
PS ratio:   134.72
Return on equity:   -167.65%
Net income %:   -9,887.24%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy